TY - JOUR
T1 - A B-vitamin mixture reduces the requirements of diclofenac after tonsillectomy
T2 - A double-blind study
AU - Medina-Santillán, Roberto
AU - Pérez-Flores, Eusebio
AU - Mateos-García, Eduardo
AU - Reyes-García, Gerardo
AU - Granados-Soto, Vinicio
AU - Flores-Murrieta, Francisco Javier
PY - 2005/9
Y1 - 2005/9
N2 - Pain observed after tonsillectomy is often severe and frequently requires the use of opioid analgesics. Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the need or avoid the use of opioids, but gastrointestinal side effects may limit their use. Sparing analgesic agents may reduce the requirement for NSAIDs and consequently their toxicity. It has been proposed that a B-vitamin mixture produces analgesia in experimental pain models. The present study was carried out to establish if a B-vitamin mixture was additive with the NSAID, diclofenac, in the treatment of postquirurgic pain. Two groups of 20 subjects, participated in the study. Group 1 received a B-vitamin mixture infusion for 12 h before the tonsillectomy, whereas Group 2 received vehicle. Both groups received a 50-mg diclofenac i.v. 8 h before surgery. Two hours after tonsillectomy, Group 1 received another B-vitamin mixture infusion for 12 h and Group 2 again received vehicle. Pain intensity was evaluated by a visual analog scale (VAS). Then diclofenac (50 mg i.v.) was administered as required by the patient without exceeding 150mg daily. Diclofenac consumption was recorded and VAS was evaluated for 54 h. Group 1 exhibited a lower pain intensity 2 h after tonsillectomy. Both groups showed similar analgesia. However, diclofenac consumption was approximately 30% lower in the group treated with the B-vitamin mixture. These results indicate that B vitamins can spare the use of analgesic agents.
AB - Pain observed after tonsillectomy is often severe and frequently requires the use of opioid analgesics. Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the need or avoid the use of opioids, but gastrointestinal side effects may limit their use. Sparing analgesic agents may reduce the requirement for NSAIDs and consequently their toxicity. It has been proposed that a B-vitamin mixture produces analgesia in experimental pain models. The present study was carried out to establish if a B-vitamin mixture was additive with the NSAID, diclofenac, in the treatment of postquirurgic pain. Two groups of 20 subjects, participated in the study. Group 1 received a B-vitamin mixture infusion for 12 h before the tonsillectomy, whereas Group 2 received vehicle. Both groups received a 50-mg diclofenac i.v. 8 h before surgery. Two hours after tonsillectomy, Group 1 received another B-vitamin mixture infusion for 12 h and Group 2 again received vehicle. Pain intensity was evaluated by a visual analog scale (VAS). Then diclofenac (50 mg i.v.) was administered as required by the patient without exceeding 150mg daily. Diclofenac consumption was recorded and VAS was evaluated for 54 h. Group 1 exhibited a lower pain intensity 2 h after tonsillectomy. Both groups showed similar analgesia. However, diclofenac consumption was approximately 30% lower in the group treated with the B-vitamin mixture. These results indicate that B vitamins can spare the use of analgesic agents.
UR - http://www.scopus.com/inward/record.url?scp=32544439391&partnerID=8YFLogxK
U2 - 10.1002/ddr.20036
DO - 10.1002/ddr.20036
M3 - Artículo
SN - 0272-4391
VL - 66
SP - 36
EP - 39
JO - Drug Development Research
JF - Drug Development Research
IS - 1
ER -